Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P-A JOINING APhA AS CO-SPONSOR OF OTC PRODUCT MARKETING PROGRAM

Executive Summary

P-A JOINING APhA AS CO-SPONSOR OF OTC PRODUCT MARKETING PROGRAM at the pharmacy assn.'s annual meeting set for Feb. 16-21 in San Antonio. In an Aug. 30 speech to the Florida Pharmacy Assn. meeting, APhA President Jack Schlegel said that P-A is assisting in the presentation of a program entitled "Marketing Your Non-Rx Dept." which can be used by pharmacists as a "tool" to help "adapt to change." Schlegel told the Florida pharmacists that the P-A/APhA marketing program on OTCs "will make the case for treating your non-Rx drug dept. more like your Rx dept. rather than just another up-front merchandise section." Representatives from several whslr. firms that offer OTC marketing assistance to their pharmacy customers will conduct workshops at the session, Schlegel said, adding: "In other words, it's going to be a 'how to' program." The cooperation on the annual meeting program is another indication that APhA and P-A are smoothing over the rift that developed between the two assns. this year over the Rx-to-OTC switch trend and the restricted OTC drug sales issue. The first sign of a rapprochement came on Aug. 10 when Schlegel paid a get-acquainted visit to P-A President Jim Cope.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS007128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel